These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8089229)

  • 41. [A case of IgD (lambda) myeloma with acute renal failure due to Bence Jones protein nephropathy successfully treated by plasma exchange].
    Akahonai Y; Abe T; Hirata H; Ban N; Nomura T; Ohshima T; Suga M; Yachi A
    Rinsho Ketsueki; 1984 Feb; 25(2):176-81. PubMed ID: 6433071
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunological diagnosis of IgD paraprotein.
    Chen CY; Chuang CY; Lin HT; Chiang FT
    J Immunol Methods; 1976; 13(3-4):207-13. PubMed ID: 1010937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins.
    Isobe T; Osserman EF
    N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196
    [No Abstract]   [Full Text] [Related]  

  • 44. Younger age of presentation and extraosseous tumour in IgD myelomatosis.
    Hobbs JR; Corbett AA
    Br Med J; 1969 Feb; 1(5641):412-4. PubMed ID: 4179168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A lambda Bence-Jones protein with an unusual amino acid sequence].
    Zlotnick A
    Harefuah; 1969 Nov; 77(9):399-401. PubMed ID: 5397693
    [No Abstract]   [Full Text] [Related]  

  • 46. Two cases of gamma-D myeloma.
    Duggin GG; Penny R
    Aust N Z J Med; 1971 Feb; 1(1):72-5. PubMed ID: 5284088
    [No Abstract]   [Full Text] [Related]  

  • 47. IgD multiple myeloma preceding the development of extensive extramedullary disease without medullary involvement.
    Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kakishita E
    Acta Haematol; 2000; 104(1):42-5. PubMed ID: 11111122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgD myeloma with myelofibrosis and amyloidosis.
    Udoji WC; Pemmaraju S
    Arch Pathol Lab Med; 1977 Jan; 101(1):10-3. PubMed ID: 401635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgD myeloma with multiple cutaneous plasmacytomas.
    Patel K; Carrington PA; Bhatnagar S; Houghton JB; Routledge RC
    Clin Lab Haematol; 1998 Feb; 20(1):53-5. PubMed ID: 9681212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors in IgD myeloma: a study of 21 cases.
    Fibbe WE; Jansen J
    Scand J Haematol; 1984 Nov; 33(5):471-5. PubMed ID: 6515330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
    Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
    CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.
    Bladé J; Lust JA; Kyle RA
    J Clin Oncol; 1994 Nov; 12(11):2398-404. PubMed ID: 7964956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IgD multiple myeloma with renal involvement: case report.
    Homan H; Ohtubo Y; Ito H; Azuma K; Yasumoto Y; Ohtuka H; Uomizu K; Yamashita W; Uemura S; Ohsaki K
    Jpn J Med; 1990; 29(2):212-5. PubMed ID: 2232370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bence Jones proteinuria and myeloma kidney.
    Chauveau D; Choukroun G
    Nephrol Dial Transplant; 1996 Mar; 11(3):413-5. PubMed ID: 8671805
    [No Abstract]   [Full Text] [Related]  

  • 55. Correlation of radiological manifestations of multiple myeloma with immunoglobulin abnormalities and prognosis.
    Gompels BM; Votaw ML; Martel W
    Radiology; 1972 Sep; 104(3):509-14. PubMed ID: 5051466
    [No Abstract]   [Full Text] [Related]  

  • 56. [IgD myeloma. Apropos of a case].
    Alcalay M; Gombert J; Frocrain C; Bontoux D
    Sem Hop; 1975 Apr; 51(18):1227-34. PubMed ID: 175473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Systemic amyloidosis associated with IgD-λ multiple myeloma].
    Nagamachi Y; Yamauchi N; Muramatsu H; Inomata H; Nozawa E; Koyama R; Ihara K; Nishisato T; Yamada H; Yano T; Kikuchi S; Hirako T; Kitaoka K; Ono K; Ihara H; Kato J
    Rinsho Ketsueki; 2011 Dec; 52(12):1888-92. PubMed ID: 22241157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.
    Zagouri F; Kastritis E; Symeonidis AS; Giannakoulas N; Katodritou E; Delimpasi S; Repousis P; Terpos E; Dimopoulos MA;
    Eur J Haematol; 2014 Apr; 92(4):308-12. PubMed ID: 24460646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathologic quiz case: an 81-year-old woman with compression fracture and renal failure. Multiple myeloma with a monoclonal serum IgD lambda immunoglobulin.
    Poulos CK; Ryder KW
    Arch Pathol Lab Med; 2003 Oct; 127(10):1383-4. PubMed ID: 14521448
    [No Abstract]   [Full Text] [Related]  

  • 60. Renal involvement in IgD myeloma.
    Bergesio F; Salvadori M; Lombardi M; Michelassi S; Salerno A; Monzani G; Florian A; Imreh F; Guidi S
    Scand J Urol Nephrol; 1988; 22(4):309-12. PubMed ID: 3238338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.